DVS Sciences
DVS Sciences develops bioanalytical solutions for use in biomarker discovery, biological research and clinical applications.
Launch date
Employees
Market cap
-
Enterprise valuation
€53—80m (Dealroom.co estimates Jul 2011.)
Sunnyvale California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$14.6m | Series A | ||
N/A | Acquisition | ||
Total Funding | €13.3m |
Related Content
Recent News about DVS Sciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.